Sandoz: Cefazolin for Injection, USP, 1 gm vial — FDA announcement Jun 27, 2025

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Jun 27, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Cefazolin for Injection, USP, 1 gm vial
Reason
Potential Presence of Penicillin G Potassium Injection Vial
Classification
Not supplied
Recalling firm
Sandoz Inc.
Quantity
Not supplied
Agency-reported status
Company recall announcement
Source record identifier
a63832019d2eba24

Open the official record

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilitySandoz, Inc. (“Sandoz”) is initiating a voluntary recall of one (1) lot of Cefazolin for Injection, USP, 1 gram per vial. This single lot is being recalled due to a customer complaint indicating that four (4) Penicillin G Potassium for Injection, USP, 20 million Units labelled vials were incorrectly included in a carton (25 vials per carton) of Cefazolin for Injection, USP 1 gram per vial product.; Sandoz is notifying its customers by letter and is arranging for return of the recalled product. The product being recalled was shipped to select wholesalers for further distribution nationwide. Healthcare providers and customers who have this product should immediately stop use of this lot only and contact Sedgwick, the Sandoz Reverse Distributor, directly by phone at (844) 491-7872 or by email at [email protected].; Product Name | Vial NDC | Carton NDC | Lot Number | Expiration Date | Manufacturer | Distributor; Cefazolin for Injection, USP(25 by 1g vials) | 0781-3451-70 | 0781-3451-96 | PG4360 | 2027-NOV | Sandoz GmbH | Sandoz Inc; Penicillin G Potassium for Injection, USP | 0781-6136-94 | N/A | PG4360 | 2027-NOV | Sandoz GmbH | Sandoz Inc

Match all identifying details in the current notice. A brand name alone is not enough.

Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

FDA company announcement, table 1
Product Name Vial NDC Carton NDC Lot Number Expiration Date Manufacturer Distributor
Cefazolin for Injection, USP(25 by 1g vials) 0781-3451-70 0781-3451-96 PG4360 2027-NOV Sandoz GmbH Sandoz Inc
Penicillin G Potassium for Injection, USP 0781-6136-94 N/A PG4360 2027-NOV Sandoz GmbH Sandoz Inc

Announcement retrieved Oct 1, 2026. Official announcement.

Distribution

Sandoz is notifying its customers by letter and is arranging for return of the recalled product. The product being recalled was shipped to select wholesalers for further distribution nationwide. Healthcare providers and customers who have this product should immediately stop use of this lot only and contact Sedgwick, the Sandoz Reverse Distributor, directly by phone at (844) 491-7872 or by email at [email protected].

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Fda listing date
Jun 27, 2025
Company announcement date
Jun 27, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records